References
1Brown WD. Osmotic demyelination disorders: central pontine and extrapontine myelinolysis. Curr Opin Neurol 2000; 13: 691-97.
2Singh TD, Fugate JE, Rabinsteinet AA. Central pontine and extrapontine myelinolysis: a systematic review. Eur J Neurol 2014; 21: 1443-50.
3Adams RA, Victor M, Mancall EL. Central pontine myelinolysis: a hitherto underdescribed desease occurring in alcoholics and malnourished patients. AMA Arch Neurol Psychiatry 1959; 81: 154-72.
4Ismail FY, Szóllics A, Szólics M, Nagelkerke N, Ljubisavljevic M. Clinical semiology and neuroradiologic correlates of acute hypernatremic osmotic challenge in adults: a literature review. AJNR Am J Neuroradiol 2013; 34: 2225-32.
5Lambeck J, Hieber M, Dreßing A, Niesen WD. Central pontine myelinosis and osmotic demyelination syndrome. Dtsch Arztebl Int 2019; 116: 600-6.
6Kallakatta RN, Radhakrishnan A, Fayaz RK, Unnikrishnan JP, Kesavadas C, Sarma SP: Clinical and functional outcome and factors predicting prognosis in osmotic demyelination syndrome (central pontine and/or extrapontine myelinolysis) in 25 patients. J Neurol Neurosurg Psychiatry 2011; 82: 326-31.
7de Souza A. Movement disorders and the osmotic demyelination syndrome. Parkinsonism Relat Disord 2013; 19: 709-16.
8Alleman AM. Osmotic demyelination syndrome: central pontine myelinolysis and extrapontine myelinolysis. Semin Ultrasound CT MR 2014; 35: 153-9.
9Hsu CCT, Krings T. Toxic and acquired metabolic conditions, acquired metabolic diseases. In: Barkhof F, Jäger HR, Thurnher MM, Rovira A, editors. Clinical Neuroradiology. Springer Nature Switzerland AG; 2019; p. 1459-98.
10Osborn AG. Acquired metabolic and systemic disorders. Osborn AG, editor. Osborn’s Brain 2nd Edition Imaging, Pathology, and Anatomy. Elsevier Canada; 2018.p.1062-68.
11Guo Y, Hu J, Zheng K, Lin W. Central pontine myelinolysis after liver transplantation: MR diffusion, spectroscopy, and perfusion findings. Magn Reson Imaging 2006; 24: 1395-98.
